Frequency Therapeutics Inc
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-0.84 | 40.3 | -102.09% | -1.27 | -33.64% |
| P/S |
|
149.7 | 29.32 | 410.62% |
|
|
| P/BV |
|
2.12 | -2038.46 | -100.1% |
|
|
| P/FCF |
|
-0.9 | 279.47 | -100.32% |
|
|
| Ev/Ebitda |
|
-3.72 | -870.14 | -99.57% |
|
|
| Ev/S |
|
144.91 | 16.27 | 790.69% |
|
|
| Ev/FCF |
|
-4.22 | -715.09 | -99.41% |
|
|
| E/P |
|
-1.19 | -0.0041 | 29282.72% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-3890.14 | 11.27 | -34628.25% | -2396.32 | +62.34% |
| ROE |
|
-50.61 | 385.88 | -113.11% |
|
|
| ROA |
|
-37.32 | -51.45 | -27.46% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
-3680.36 | 9.89 | -37331.77% |
|
|
| ROCE |
|
-57.3 | 5.27 | -1188.32% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.51 | 0.12 | -505.81% | -0.4 | +27.57% |
| Nеt Debt/Ebitda |
|
0.12 | -0.83 | -114.78% |
|
|
| Debt/Ratio |
|
0.2 | 0.0799 | 147.64% |
|
|
| Debt/Equity |
|
0.41 | -1.66 | -124.78% |
|
|
| Debt/Net Income |
|
-0.54 | 0.17 | -416.65% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0 | 0% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0 | 0% | ||
| DSI |
|
0 | 0 | 0% |
|
|
| Average dividend growth |
|
0 | 0 | 0% |
|
|
| Average percentage for 5 years |
|
0 | 0 | 0% |
|
|
| Average percentage for payments |
|
0 | 0 | 0% |
|
|
| Difference from average difference in sector |
|
0 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-92.15 | 294.53 | -131.29% | ||
| Growth impulse Ebitda in 5 years |
|
240.18 | 484.36 | -50.41% | ||
| Growth impulse Net Income in 5 years |
|
215.27 | 272.24 | -20.93% | ||
| Growth impulse FCF in 5 years |
|
50.36 | -63.92 | -178.79% | ||
| Growth impulse EPS in 5 years |
|
1056.73 | -235.49 | -548.74% |
IP Score
4.21/10
